Related Experiment Videos

Chemotherapy of experimental (murine) Clostridium perfringens type A gas gangrene

W H Traub1

  • 1Institut für Medizinische Mikrobiologie und Hygiene, Universität des Saarlandes, Homburg, BRD.

Chemotherapy
|January 1, 1988
PubMed

Insights

Imipenem effectively treated gas gangrene caused by Clostridium perfringens in mice, while penicillin G was ineffective. Other antimicrobials showed intermediate efficacy in this crucial study.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Gas gangrene is a severe soft tissue infection caused by Clostridium perfringens.
  • Antimicrobial therapy is a cornerstone of gas gangrene treatment.
  • Understanding the comparative efficacy of different antibiotics is critical for clinical decision-making.

Purpose of the Study:

  • To evaluate the therapeutic efficacy of five key antimicrobial drugs against Clostridium perfringens type A in a murine model of gas gangrene.
  • To determine the relative effectiveness of ciprofloxacin, clindamycin, imipenem, penicillin G, and rifampin.

Main Methods:

  • A murine model of gas gangrene was established using large inocula of Clostridium perfringens type A.
  • The efficacy of ciprofloxacin, clindamycin, imipenem, penicillin G, and rifampin was assessed in vivo.
  • Six different strains of C. perfringens were utilized in the experimental model.

Main Results:

  • Imipenem demonstrated significant therapeutic efficacy, proving effective against all six tested strains of C. perfringens.
  • Penicillin G failed to show efficacy against any of the six C. perfringens strains.
  • Ciprofloxacin, clindamycin, and rifampin exhibited intermediate levels of efficacy, falling between imipenem and penicillin G.

Conclusions:

  • Imipenem is a highly effective antimicrobial agent for treating gas gangrene caused by Clostridium perfringens.
  • Penicillin G is not recommended for treating gas gangrene due to C. perfringens in this model.
  • Further clinical investigation is warranted to confirm the efficacy of imipenem and other tested antimicrobials in human patients.

Related Concept Videos